For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

2Seventy Bio, Inc.

USPTO Granted Patents = 23

CIPO Patents = 1

EPO Patents = 6

Trademarks = 4

Forward Citations = 49

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Kevin Friedman (11 out of 21 patents)

Jordan Jarjour (7 out of 23 patents)

Richard Morgan (6 out of 14 patents)

4. Kyle Havens (3 out of 9 patents)

5. Jasdeep Mann (2 out of 6 patents)

6. Joel Gay (2 out of 3 patents)

7. Joy Zhang (2 out of 3 patents)

8. Molly Reed Perkins (2 out of 5 patents)

9. Alexander Astrakhan (2 out of 9 patents)

10. Michael Certo (2 out of 5 patents)

11. Wai-hang Leung (2 out of 6 patents)

12. Anne-Rachel Krostag (1 out of 5 patents)

13. Baeckseung Lee (1 out of 2 patents)

14. Mark Pogson (1 out of 5 patents)

15. Benjamin Boyerinas (1 out of 3 patents)

23 patents: Sort by Forward Citations

1. 12644099 - Methods for making T cell compositions (2026-06-02),

2. 12545746 - ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE (2026-02-10),

3. 12291722 - Methods for manufacturing adoptive cell therapies (2025-05-06),

4. 12247084 - Anti-BCMA CAR antibodies, conjugates, and methods of use (2025-03-11),

5. 12109234 - Anti-BCMA CAR T cell compositions (2024-10-08),

6. 12029784 - BCMA chimeric antigen receptors (2024-07-09),

7. 12006369 - BCMA chimeric antigen receptors (2024-06-11),

8. 11976116 - Salvage chimeric antigen receptor systems (2024-05-07),

9. 11952413 - Dimerizing agent regulated immunoreceptor complexes comprising interleukin receptor signaling domains (2024-04-09),

10. 11912746 - PD-1 homing endonuclease variants, compositions, and methods of use (2024-02-27),

11. 11779654 - PCSK9 endonuclease variants, compositions, and methods of use (2023-10-10),

12. 11732255 - CBLB endonuclease variants, compositions, and methods of use (2023-08-22),

13. 11654158 - TGFBeta signal convertor (2023-05-23),

14. 11633463 - BCMA chimeric antigen receptors (2023-04-25),

15. 11591582 - TCRα homing endonuclease variants (2023-02-28),

2seventy bio, Inc. is a biotechnology company focused on developing innovative solutions for various healthcare challenges. Our team is dedicated to creating breakthrough therapies and diagnostics to improve patients' lives. With a strong emphasis on research and development, we strive to address unmet medical needs and deliver transformative healthcare products. Visit our website to learn more about our cutting-edge technologies and ongoing projects.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

23 Patents

#122 in Cambridge, MA

#862 in Massachusetts

#14,382 in US

#27,577 in the World

Cambridge, MA, United States of America

2Seventy Bio, Inc.

Forward Citations = 49

19 inventors:

Kevin Friedman (11 out of 21 patents)

Jordan Jarjour (7 out of 23 patents)

Richard Morgan (6 out of 14 patents)

4. Kyle Havens (3 out of 9 patents)

5. Jasdeep Mann (2 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…